Minimally invasive surfactant therapy failure: risk factors and outcome

LCE Janssen, J Van Der Spil, AH van Kaam… - Archives of Disease in …, 2019 - fn.bmj.com
Objective To evaluate incidence of minimally invasive surfactant therapy (MIST) failure,
identify risk factors and assess the impact of MIST failure on neonatal outcome. Design …

Short-term outcome after repeated less invasive surfactant administration: a retrospective cohort study

LMP Kleijkers, J Van Der Spil, LCE Janssen… - Neonatology, 2022 - karger.com
Introduction: Less invasive surfactant administration (LISA) to preterm infants is associated
with decreased risk for death or BPD. After LISA, a considerable proportion requires a …